Medical Affairs and Strategy
• Served as the subject matter expert for various therapeutic areas (such as oncology, neurology, and rare diseases) providing authoritative guidance and insights to cross-functional teams and ensuring content is scientifically accurate and relevance
• Ensured the accuracy, appropriateness, and strategic alignment of clinical and HEOR content for managed markets projects, collaborating with internal teams to develop evidence-based client materials and internal training presentations.
• Synthesized extensive epidemiological, clinical, and economic outcomes data into sophisticated reports utilizing proficiency with Microsoft Excel, PowerPoint slide decks, and Word documents, to deliver actionable insights to medical affairs and communications departments
• Experienced in the MLR review process, ensuring compliance with regulatory and client-specific guidelines while developing and reviewing medical/scientific content in Neurology and Hematology.
Medical

• Supported clinical research team in the management of three-multi-centered Phase I and Phase II clinical trials in respiratory, CV, oncology, and infectious disease.
• Utilized digital innovation to create educational content surrounding complex drug information topics, breaking them down into easily digestible formats to train various audiences such as principal investigators and site coordinators.
• Aided in the development of clinical study reports, IBs, INDs, and MAAs for EU directives with comprehensive medical device logistics, safety, and efficacy data.
• Project manager over internal and client projects to assure compliance with FDA and EU standards.
• Experienced reviewing, analyzing, and programming EDC (electronic data capture) systems.
• Continuously updated and monitored the trial master file (TMF).
• Leverage critical thinking and collaborative skills to solve complex problems and improve healthcare outcomes Selected engagements:
• Managed European-based clinical

• Developed price and market access inputs into forecasts and ensured assumptions were aligned across the brand portfolio to give a robust forecast.
• Provided market insights by leveraging knowledge of market access landscape, patient claims data, and formulary data.
• Monitored ongoing trends in the external environment that could Influence future BMS forecast strategies. Selected engagement:
• Forecasted future payer and KOL management and reimbursement for a novel cardiovascular drug through comprehensive competitor market analysis.
ADDITIONAL WORK EXPERIENCE